SICEM 2026

SICEM partner highlights: Featured oral session Day 1, Thursday, April 9, 16:30-18:00 / Room 2

Chairpersons: Em Yunir (University of Indonesia, Indonesia), SungHee Choi (Seoul National University, Korea)

	16:30-16:40	Joint longitudinal survival evaluation of bone density decline with trabecular microarchitecture loss linking vertebral fracture risk to cancer recurrence trajectories in postmenopausal women receiving aromatase inhibitor therapy Darius Laia (Gema Economy Indonesia, Magelang, Indonesia)
	16:40-16:50	Depot-specific and common patterns of subcutaneous and visceral adipocyte geometry and adiposity parameters across systolic and diastolic blood pressure in Thai females Pailin Maikaew (Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand)
	16:50-17:00	Conservative counterfactual deep reinforcement learning for glycemic stabilization and acute kidney injury prevention in hospitalized adults with diabetes using safety-constrained clinical decision support Prihantini Prihantini (IMCDS-BioMed Research Foundation, Indonesia)
	17:00-17:10	The effects of DRD2/ANKK1 gene polymorphisms related to food desire on mental health, eating behaviour, and physical activity levels in the 'Fit-for-Future' weight management program Norazmir Md Nor (Universiti Teknologi MARA, Universiti Teknologi MARA, Universiti Teknologi MARA, Malaysia)
	17:10-17:20	Prevalence and association of diabetic peripheral neuropathy and severity of coronary artery disease among adults with diabetes mellitus undergoing coronary angiography: A single-center cross-sectional study Precious Diamond Chua-See (Cardinal Santos Medical Center, Philippines)
	17:20-17:30	Machine learning-driven safety-aware decision support for predicting near-term inpatient hypoglycemia under dynamic insulin, nutrition, and renal function interactions Riana Dwi Kurniawati (Temanggung Public Health Center, Indonesia)
	17:30-17:40	Time-restricted eating improves diet and sleep quality in overweight and obese adults with cardiometabolic comorbidity: TRES randomized controlled trial Mazuin Kamarul Zaman (Universiti Teknologi MARA, Malaysia)
	17:40-17:50	Peer to peer insulin sharing and unstable glycemia in financially strained households quantified by network based causal models integrating CGM coefficient of variation, emergency hypoglycemia visits, prescription refill gaps, and copayment shock exposure Ayuni Kemala Safira (Bandung Institute of Technology, Indonesia)
	17:50-18:00	Radiofrequency ablation for benign solid thyroid nodules larger than 10 mL: A prospective study on efficacy and safety Bang Nguyen Van (Da Nang Family hospital, Hue University of Medicine and Pharmacy, Hue University, Vietnam)

ES-KES joint symposium Advances in osteoporosis and antiresorptive therapy Day 2, Friday, April 10, 08:30-10:00 / Room 3 Overview: This ES–KES joint symposium provides a comprehensive overview of current clinical challenges and advances in antiresorptive therapy. Topics include management of treatment sequences following denosumab discontinuation, the impact of antiresorptive therapies on systemic health and longevity beyond fracture prevention, and their role in cancer-related bone diseases. The session aims to enhance clinical decision-making and translational understanding for both clinicians and researchers.

Chairpersons: Robert Lash (Endocrine Society, USA), Sang Wan Kim (Seoul National University, Korea)

	08:30-09:00	Managing osteoporosis treatment sequences with denosumab discontinuation Elaine W. Yu (Harvard Medical School, USA)
	09:00-09:30	From bone health to lifespan: Why antiresorptive therapy matters beyond fracture prevention Kyoung Jin Kim (Korea University, Korea)
	09:30-10:00	Bone as a battleground: Anti-resorptives in cancer-related bone diseases Gregory Clines (University of Michigan, USA)

Rising stars in endocrinology Day 3, Saturday, April 11, 08:30-10:00 / Room 2 Overview: The rising stars in Endocrinology session presents cutting-edge research and clinical insights from emerging leaders. Topics include immune checkpoint inhibitor–related endocrine dysfunction, disease-modifying strategies in Graves’ disease and thyroid eye disease, advances in fracture risk assessment, and prevention of rebound phenomena after denosumab. The session emphasizes future directions in endocrinology through clinically relevant, translational perspectives.

Chairpersons : Jenny Gunton (University of Sydney, Australia), Sunghwan Suh (Sungkyunkwan University, Korea)

	08:30-08:50	Immune checkpoint inhibitor-related endocrine dysfunction Tomoko Kobayashi (Nagoya University, Japan)
	08:50-09:10	Shifting paradigms in Graves' disease and thyroid eye disease: Towards disease-modifying strategies Chia-Hung Lin (National Taiwan University, Taiwan)
	09:10-09:30	From snapshot to movie: The evolution of fracture risk assessment Sung Hye Kong (Seoul National University, Korea)
	09:30-09:50	Rebound phenomenon after denosumab: Translational insights into prevention Albert Sungsoo Kim (University of Sydney, Australia)
	09:50-10:00	Q&A

PCEDM-KES joint symposium Practical approach in treatment of endocrine diseases Day 3, Saturday, April 11, 14:50-16:20 / Room 4 Overview: This PCEDM–KES joint symposium promotes academic exchange with the Philippines, an active international participant at SICEM. It focuses on practical, evidence-based management of common endocrine diseases in Asian populations. Key topics include sequential therapy in osteoporosis, subclinical hypothyroidism, and newer antidiabetic agents. Speakers present guideline-based, clinically applicable treatment strategies. The session supports effective clinical decision-making and future collaboration.

Chairpersons : Lora May T. Tin Hay (Philippine College of Endocrinology, Diabetes and Metabolism, Philippines), Eun-Gyoung Hong (Hallym University, Korea)

	14:50-15:20	Sequential therapy in osteoporosis: When, how and for whom? Monica Therese Cating-Cabral (Philippine College of Endocrinology, Diabetes and Metabolism, Philippines)
	15:20-15:50	Subclinical hypothyroidism in real-world practice: Whom to treat and how to monitor? Jeongmin Lee (The Catholic University of Korea, Korea)
	15:50-16:20	Newer antidiabetic agents in daily clinical practice: When and how to use Wonjin Kim (CHA University, Korea)

Scientific program

Joint symposium